NDC 00078-0834-30: Patanase olopatadine hydrochloride 600 ug Spray, Metered
This is a package of Patanase olopatadine hydrochloride 600 ug Spray, Metered from Novartis Pharmaceuticals Corporation, no longer marketed, no longer in the FDA NDC Directory. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 0078-0834-30 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 0078 labeler · 0834 product · 30 package
- Barcode (UPC-A, from the NDC)
- 3 0078083430 8
- FDA record last changed
- Mar 13, 2024
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 063890
- GCN: 99602
- HICL (First Databank): 012815
- AHFS class code: 52:02.00.00
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Olopatadine nasal spray is used to relieve sneezing and a stuffy, runny or itchy nose caused by allergic rhinitis (hay fever). Olopatadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms.
Read the full MedlinePlus article ↗- It treats allergy symptoms. The eye drops relieve itchy eyes, and some also relieve red eyes, from things like pollen and pet dander. Prescription eye drops treat allergic conjunct...
- It depends on the product. Some over-the-counter drops are used twice a day, 6 to 8 hours apart, and others once a day. Check your package, and don’t use more than it says.
- How often do I use olopatadine eye drops?
- Take your lenses out before putting in the drops. Wait at least 10 minutes before putting them back in. Don’t wear lenses if your eye is red, and don’t use the drops for irritation...
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Olopatadine Hydrochloride — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 00078-0834-30 You're viewing this Main listing | 1 BOTTLE in 1 CARTON / 240 SPRAY, METERED in 1 BOTTLE | 2021-12-24 | — | Discontinued by firm |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Patanase 600 ugthis 00078-0834-30 | Novartis | 1 bottle | — | — | Discontinued | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Olopatadine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Novartis Pharmaceuticals Corporation labeler code 00078
- ENTRESTO Sacubitril and Valsartan 49 mg; 51 mg Tablet, Film Coated NDC 0078-0777-20
- Sandostatin LAR Depot octreotide acetate Kit NDC 0078-0811-81
- Tobrex tobramycin 3 mg/g Ointment NDC 0078-0813-01
- Sandostatin LAR Depot octreotide acetate Kit NDC 0078-0818-81
- Sandostatin LAR Depot octreotide acetate Kit NDC 0078-0825-81
- BEOVU brolucizumab 6 mg/.05mL Injection, Solution NDC 0078-0827-60
- Kymriah tisagenlecleucel 2000000 1/1 Injection, Suspension NDC 0078-0846-19
- Kisqali ribociclib 200 mg Tablet, Film Coated NDC 0078-0860-01
- Kisqali ribociclib 200 mg Tablet, Film Coated NDC 0078-0867-42
- Kisqali ribociclib 200 mg Tablet, Film Coated NDC 0078-0874-63
- TobraDex tobramycin and dexamethasone 1 mg/g; 3 mg/g Ointment NDC 0078-0876-01
- ADAKVEO crizanlizumab 10 mg/mL Injection NDC 0078-0883-61
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |